Evidence map›Paper›PMID 34065159›Full record

ArticleCurrent issues in molecular biology2021

Critical Amino Acid Variants in HLA-DRB1 and -DQB1 Allotypes in the Development of Classical Type 1 Diabetes and Latent Autoimmune Diabetes in Adults in the Japanese Population.

Masahito Katahira, Taku Tsunekawa, Akira Mizoguchi, Mariko Yamaguchi, Kahori Tsuru, Hiromi Takashima, Ryoma Terada

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Current issues in molecular biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Masahito KatahiraNursing and Health, Aichi Prefectural University School of Nursing and Health, Togoku, Kamishidami, Moriyama-ku, Nagoya 463-8502, Japan.ORCID 0000-0001-5250-8138
Taku TsunekawaDepartment of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22, Bunkyo, Ichinomiya 491-8558, Japan.ORCID 0000-0003-1609-4550
Akira MizoguchiDepartment of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22, Bunkyo, Ichinomiya 491-8558, Japan.
Mariko YamaguchiDepartment of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22, Bunkyo, Ichinomiya 491-8558, Japan.
Kahori TsuruDepartment of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22, Bunkyo, Ichinomiya 491-8558, Japan.
Hiromi TakashimaDepartment of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22, Bunkyo, Ichinomiya 491-8558, Japan.
Ryoma TeradaDepartment of Endocrinology and Diabetes, Ichinomiya Municipal Hospital, 2-2-22, Bunkyo, Ichinomiya 491-8558, Japan.
Ichinomiya Municipal City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of amino acid variants encoded by the human leukocyte antigen (HLA) class II on the development of classical type 1 diabetes (T1D) and latent autoimmune diabetes in adults (LADA) have not been fully elucidated. We retrospectively investigated the

Indexed as

AdolescentAdultAgedAged, 80 and overAllelesAmino Acid SubstitutionChildChild, PreschoolDiabetes Mellitus, Type 1FemaleHaplotypesHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansJapanLatent Autoimmune Diabetes in AdultsHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 Chainsamino acid variantsHLA class IIlatent autoimmune diabetes in adultstype 1 diabetes

Identifiers

PMID34065159
PMCPMC8928954
OpenAlexW3162748472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.